ERIN HAYNES: Open Payments
NPI 1356621346 · MOLINE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 36 payments from 11 companies in 2025. Trend: 2023 $521 · 2024 $829 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $373 |
| Janssen Biotech, Inc. | 3 | $66 |
| Ipsen Biopharmaceuticals, Inc | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Endologix LLC | 1 | $40 |
| GENZYME CORPORATION | 2 | $33 |
| Lilly USA, LLC | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
| Celltrion USA Inc. | 1 | $15 |
Products named: RINVOQ, CREON, TREMFYA, IQIRVO, ENTYVIO, AFX2 Bifurcated Endograft System, LINZESS, DUPIXENT.
Industry payments across IL — which companies pay providers there.
